Home » EPIC Archives: AZN

AZN News Archives



AstraZeneca Imfinzi granted FDA Priority Review

Astrazeneca plc

AstraZeneca (LON:AZN) today announced that the US Food and Drug Administration has accepted a supplemental Biologics License Application and granted Priority Review for Imfinzi for the treatment of patients with previously untreated extensive-stage ...

Read Article »